Αποτελέσματα Αναζήτησης
18 Απρ 2019 · Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus
- View Epub
”GØí°³·äÂöG ¬Mö ßfØk9+ Ü‹”ƒ¤’ Rà‰à¯Âw, ]ù ]9ºêXh,À~â B=t/ÒS...
- Circulation Research
The past 3 decades have been characterized by an exponential...
- Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus
Results: The study population included 5386 patients with...
- View Epub
8 Μαρ 2024 · During atrial fibrillation, the heart's upper chambers — called the atria — beat chaotically and irregularly. They beat out of sync with the lower heart chambers, called the ventricles. For many people, AFib may have no symptoms. But AFib may cause a fast, pounding heartbeat, shortness of breath or light-headedness.
10 Νοε 2021 · In this multicenter cohort study of 2411 patients with documented atrial fibrillation, we found that patients with diabetes less often perceive atrial fibrillation symptoms, although they have worse quality of life and more cardiac and neurological comorbidities than patients without diabetes.
7 Δεκ 2021 · In the systematic review, 8 studies among patients with AF investigated the cross-sectional association of diabetes with non-paroxysmal AF (vs paroxysmal) of which 6 showed a positive association and 2 showed no association.
DM is a known risk factor for thromboembolic events in patients with AF, and is associated with a 70% relative increase in risk of stroke (55). Diabetes is included in the CHA 2 DS 2 -VASc risk score, which is widely used to assess stroke risk and guide anticoagulation therapy (56).
Interestingly, NOACs were found to reduce the risk of MALE in atrial fibrillation patients with diabetes when compared with warfarin. This was seen in a retrospective claims’ analysis in patients with atrial fibrillation and comorbid diabetes. The study identified 10 700 people treated with rivaroxaban and 13 946 patients treated with warfarin.
18 Ιαν 2020 · Individuals with type 2 diabetes had an overall 35% higher risk of atrial fibrillation compared to age- and sex-matched controls from the general population. The excess risk for atrial fibrillation increased with renal complications or with poor glycaemic control.
